These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6818587)

  • 21. Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
    Dencker SJ; Lepp M; Malm U
    Acta Psychiatr Scand Suppl; 1980; 279():64-76. PubMed ID: 6105763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
    Dencker SJ; Malm U; Jørgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
    Jrgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of the depot antipsychotics.
    Jann MW; Ereshefsky L; Saklad SR
    Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical experiences with depot neuroleptics].
    Peterová E; Baudis P; Dvoráková M; Vencovský E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():173-6. PubMed ID: 829618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose flupenthixol decanoate in chronic schizophrenia.
    McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
    Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
    Chowdhury ME; Chacon C
    Compr Psychiatry; 1980; 21(2):135-9. PubMed ID: 6991205
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
    Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative trail of fluphenazine decanoate and flupenthixol decanoate.
    Haslam MT; Bromham BM; Schiff AA
    Acta Psychiatr Scand; 1975 Feb; 51(2):92-100. PubMed ID: 1091124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schizophrenic relapse after drug withdrawal is predictable.
    Dencker SJ; Malm U; Lepp M
    Acta Psychiatr Scand; 1986 Feb; 73(2):181-5. PubMed ID: 3705994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.
    Stauning JA; Kirk L; Jøorgensen A
    Psychopharmacology (Berl); 1979 Sep; 65(1):69-72. PubMed ID: 116292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disturbed behavior induced by high-dose antipsychotic drugs.
    Barnes TR; Bridges PK
    Br Med J; 1980 Jul; 281(6235):274-5. PubMed ID: 7427243
    [No Abstract]   [Full Text] [Related]  

  • 39. Delusions of infestation: treatment by depot injections of neuroleptics.
    Frithz A
    Clin Exp Dermatol; 1979 Dec; 4(4):485-8. PubMed ID: 535177
    [No Abstract]   [Full Text] [Related]  

  • 40. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)].
    Eufe R; Wegener G
    Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.